Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Cancer. 2016 Apr 18;122(13):2110–2116. doi: 10.1002/cncr.30025

Table 1.

Baseline Characteristics of Study Participants, N=350

Clinical Characteristics Mean (SD) or N (%)
Age, years 64.86 (10.86)
  ≥65 176 (50.3)

Sex
  Male 189 (54.0)
  Female 161 (46.0)

Race
  White 323 (92.3)
  African American 10 (2.9)
  Asian 8 (2.3)
  American Indian or Alaska Native 4 (1.1)
  Other 5 (1.4)

Hispanic or Latino ethnic group 9 (2.6)

Cancer Type
  Gastrointestinal 159 (45.4)
  Lung 191 (54.6)

Smoking History
  <10 pack years 142 (40.6)
  ≥10 pack years 188 (53.7)
  Unknown 20 (5.7)

ECOG performance status
  0 88 (25.1)
  1 231 (66.0)
  2 31 (8.9)

Initial cancer therapy
  Chemotherapy 278 (79.4)
  Radiation* 67 (19.1)
  Chemoradiotherapy 3 (0.9)
  No chemotherapy or radiation 2 (0.6)

Religion
  Catholic 201 (57.6)
  Protestant 62 (17.8)
  Jewish 16 (4.6)
  Muslim 3 (0.9)
  None 41 (11.7)
  Other 26 (7.4)

Relationship Status
  Married 244 (69.7)
  Divorced 35 (10.0)
  Widowed 35 (10.0)
  Single 27 (7.7)
  Non-cohabitating relationship 6 (1.7)
  Other 3 (0.9)

Have dependent children 44 (12.6)

Education level
  ≤ High school 131 (37.4)
  > High school 219 (62.6)

Income Level
  ≤ $50,000 133 (38.0)
  >$50,000 189 (54.0)
  Missing 28 (8.0)

QOL
  FACT-G 78.31 (15.18)

Mood symptoms
  HADS-Depression 4.65 (4.01)
  HADS-Anxiety 5.31 (3.92)

Abbreviations: SD, standard deviation; ECOG, Eastern Cooperative Oncology Group; QOL, quality of life; Functional Assessment of Cancer Therapy-General (FACT-G); HADS, Hospital Anxiety and Depression Scale.

*

one person who received transarterial chemoembolization (TACE) as their initial cancer therapy is included within the radiation category